Oncology
Latest News
Doctors as trusted messengers
Oncologists are increasingly stepping up for a new role on the front lines of battling cancer-causing air pollution. A new ProPublica report...
Latest News
More evidence ties some antipsychotics to increased breast cancer risk
The relative risk for breast cancer was 62% higher in women who took category 1 antipsychotic medications associated with high prolactin levels....
Conference Coverage
Sacituzumab govitecan effective in Black mTNBC patients
Black women may have outcomes comparable to those of other women when given sacituzumab govitecan for the treatment of metastatic TNBC, suggests...
Conference Coverage
PD-L1 cutoff for pembrolizumab in mTNBC confirmed
PD-L1 CPS of at least 10 improves overall survival by 28%-29%. Further analysis of responses to pembrolizumab plus chemotherapy in metastatic TNBC...
Conference Coverage
Antibiotic use associated with triple-negative breast cancer mortality
Antimicrobials can decrease circulating and tumor-infiltrating lymphocytes that effect the immune repertoire and in turn survival.
Conference Coverage
Women struggle with benzodiazepine addiction post chemotherapy treatment
Sedatives like benzodiazepines are used to control nausea, anxiety, and insomnia during chemotherapy treatment, but overuse and failing to taper...
Latest News
FDA expands pembrolizumab approval for advanced melanoma
Approval was based on first interim findings from the randomized, placebo-controlled KEYNOTE-716 trial, which evaluated patients with stage IIB...
Conference Coverage
Genomic profiling can improve PFS in metastatic breast cancer
Genomic testing for cancer is effective, experts say. Targeted therapy may be needed when genomic alterations are present.
News
Cancer-related thyroidectomy linked to increased diabetes risk
Compared with nonthyroid cancer patients, those receiving thyroidectomy for thyroid cancer show up to a 40% greater risk for diabetes.
News
‘Highest survival’ with combo immunotherapy in advanced melanoma
The results represent the longest median overall survival seen in a phase 3 trial of advanced melanoma.
